Scheffler, M., T. Zander, L. Nogova, C. Kobe, D. Kahraman, F. Dietlein, I. Papachristou, L. Heukamp, R. Büttner, R. Boellaard, A. A. Lammertsma, S. Querings, E. Stoelben, W. Engel-Riedel, B. Neumaier and J. Wolf: Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with Erlotinib. In: PLoS ONE 8, 1, Seq. No.: e53081 (2013).
doi: 10.1371/journal.pone.0053081
Seidel, D., T. Zander, L. C. Heukamp, M. Peifer, M. Bos, L. Fernandez-Cuesta, F. Leenders, X. Lu, S. Ansen, M. Gardizi, C. Nguyen, J. Berg, P. Russell, Z. Wainer, H.-U. Schildhaus, T.-M. Rogers, B. Solomon, W. Pao, S. L. Carter, G. Getz, D. N. Hayes, M. D. Wilkerson, E. Thunnissen, W. D. Travis, S. Perner, G. Wright, E. Brambilla, R. Buettner, J. Wolf, R. Thomas, F. Gabler, I. Wilkening, C. Mueller, I. Dahmen, R. Menon, K. Koenig, K. Albus, S. Merkelbach-Bruse, J. Fassunke, K. Schmitz, H. Kuenstlinger, M. Kleine, E. Binot, S. Querings, J. Altmueller, I. Boessmann, P. Nuemberg, P. Schneider, M. Bogus, R. Buettner, A. Soltermann, H. Moch, O. T. Brustugun, S. Solberg, M. Lund-Iversen, A. Helland, T. Muley, H. Hoffmann, P. A. Schnabel, Y. Chen, H. Groen, W. Timens, H. Sietsma, J. H. Clement, W. Weder, J. Saenger, E. Stoelben, C. Ludwig, W. Engel-Riedel, E. Smit, D. A. M. Heideman, P. J. F. Snijders, L. Nogova, M. L. Sos, C. Mattonet, K. Toepelt, M. Scheffler, E. Goekkurt, R. Kappes, S. Krueger, K. Kambartel, D. Behringer, W. Schulte, W. Galetke, W. Randerath, M. Heldwein, A. Schlesinger, M. Serke, K. Hekmat, K. F. Frank, R. Schnell, M. Reiser, A.-N. Huenerlituerkoglu, S. Schmitz, L. Meffert, Y.-D. Ko, M. Litt-Lampe, U. Gerigk, R. Fricke, B. Besse, C. Brambilla, S. Lantuejoul, P. Lorimier, D. Moro-Sibilot, F. Cappuzzo, C. Ligorio, S. Damiani, J. K. Field, R. Hyde, P. Validire, P. Girard, L. A. Muscarella, V. M. Fazio, M. Hallek, J.-C. Soria, S. L. Carter, V. Achter and U. Lang: A genomics-based classification of human lung tumors. In: Science Translational Medicine 5, 209, Seq. No.: 209ra153 (2013).
doi: 10.1126/scitranslmed.3006802
Seidel, D., T. Zander, L. C. Heukamp, M. Peifer, M. Bos, L. Fernandez-Cuesta, F. Leenders, X. Lu, S. Ansen, M. Gardizi, C. Nguyen, J. Berg, P. Russell, Z. Wainer, H.-U. Schildhaus, T.-M. Rogers, B. Solomon, W. Pao, S. L. Carter, G. Getz, D. N. Hayes, M. D. Wilkerson, E. Thunnissen, W. D. Travis, S. Perner, G. Wright, E. Brambilla, R. Buettner, J. Wolf, R. Thomas, F. Gabler, I. Wilkening, C. Mueller, I. Dahmen, R. Menon, K. Koenig, K. Albus, S. Merkelbach-Bruse, J. Fassunke, K. Schmitz, H. Kuenstlinger, M. Kleine, E. Binot, S. Querings, J. Altmueller, I. Boessmann, P. Nuemberg, P. Schneider, M. Bogus, R. Buettner, A. Soltermann, H. Moch, O. T. Brustugun, S. Solberg, M. Lund-Iversen, A. Helland, T. Muley, H. Hoffmann, P. A. Schnabel, Y. Chen, H. Groen, W. Timens, H. Sietsma, J. H. Clement, W. Weder, J. Saenger, E. Stoelben, C. Ludwig, W. Engel-Riedel, E. Smit, D. A. M. Heideman, P. J. F. Snijders, L. Nogova, M. L. Sos, C. Mattonet, K. Toepelt, M. Scheffler, E. Goekkurt, R. Kappes, S. Krueger, K. Kambartel, D. Behringer, W. Schulte, W. Galetke, W. Randerath, M. Heldwein, A. Schlesinger, M. Serke, K. Hekmat, K. F. Frank, R. Schnell, M. Reiser, A.-N. Huenerlituerkoglu, S. Schmitz, L. Meffert, Y.-D. Ko, M. Litt-Lampe, U. Gerigk, R. Fricke, B. Besse, C. Brambilla, S. Lantuejoul, P. Lorimier, D. Moro-Sibilot, F. Cappuzzo, C. Ligorio, S. Damiani, J. K. Field, R. Hyde, P. Validire, P. Girard, L. A. Muscarella, V. M. Fazio, M. Hallek, J.-C. Soria, S. L. Carter, V. Achter and U. Lang: A genomics-based classification of human lung tumors. In: Science Translational Medicine 5, 209, Seq. No.: 209ra153 (2013).
doi: 10.1126/scitranslmed.3006802
Kobe, C., M. Scheffler, A. Holstein, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, R. T. Ullrich, M. Dietlein, J. Wolf and D. Kahraman: Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib. In: European Journal of Nuclear Medicine and Molecular Imaging 39, 7, 1117-1127 (2012).
doi: 10.1007/s00259-012-2118-8
Kobe, C., M. Scheffler, A. Holstein, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, R. T. Ullrich, M. Dietlein, J. Wolf and D. Kahraman: Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib. In: European Journal of Nuclear Medicine and Molecular Imaging 39, 7, 1117-1127 (2012).
doi: 10.1007/s00259-012-2118-8
Scheffler, M., C. Kobe, T. Zander, L. Nogova, D. Kahraman, R. K. Thomas, B. Neumaier, M. Dietlein and J. Wolf: Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET. In: Lung Cancer 77, 3, 617-620 (2012).
doi: 10.1016/j.lungcan.2012.05.110
Scheffler, M., C. Kobe, T. Zander, L. Nogova, D. Kahraman, R. K. Thomas, B. Neumaier, M. Dietlein and J. Wolf: Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET. In: Lung Cancer 77, 3, 617-620 (2012).
doi: 10.1016/j.lungcan.2012.05.110
Kahraman, D., A. Holstein, M. Scheffler, T. Zander, L. Nogova, A. A. Lammertsma, R. Boellaard, B. Neumaier, M. Dietlein, J. Wolf and C. Kobe: Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib. In: Clinical Nuclear Medicine 37, 11, 1058-1064 (2012).
doi: 10.1097/RLU.0b013e3182639747
Yan, Q., P. Rinke, M. Winkelnkemper, A. Qteish, D. Bimberg, M. Scheffler and C. G. Van de Walle: Band parameters and strain effects in ZnO and group-III nitrides. In: Semiconductor Science and Technology 26, 01, Seq. No.: 014037 (2011).
url: http://www.fhi-berlin.mpg.de/th/th.html
url: http://dx.doi.org/10.1088/0268-1242/26/1/014037
Querings, S., J. Altmüller, S. Ansen, T. Zander, D. Seidel, F. Gabler, M. Peifer, E. Markert, K. Stemshorn, B. Timmermann, B. Saal, S. Klose, K. Ernestus, M. Scheffler, W. Engel-Riedel, E. Stoelben, E. Brambilla, J. Wolf, P. Nürnberg and R. K. Thomas: Benchmarking of mutation diagnostics in clinical lung cancer specimens. In: PLoS ONE 6, 5, e19601-e19601 (2011).
doi: 10.1371/journal.pone.0019601
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.